81
Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)
Condition(s): HIV Infections; AIDS Last Updated: December 2, 2011Completed
738 Clinical Trials for: Treatment Interruption, Page 5 of 37
Hide Studies Not Seeking New Volunteers
82
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Condition(s): Thyroid Carcinoma Last Updated: March 13, 2013Not yet recruiting
83
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Condition(s): Hepatitis B Chronic Infection; Pregnancy Last Updated: January 3, 2013Recruiting
84
CSP #512 - Options in Management With Anti-Retrovirals
Condition(s): AIDS; HIV Infections Last Updated: October 24, 2008Completed
85
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
Condition(s): Solid Tumors Last Updated: January 20, 2012Completed
86
Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care
Condition(s): Tuberculosis Last Updated: October 23, 2007Recruiting
87
Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study
Condition(s): Diabetes Last Updated: November 6, 2012Completed
88
Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition(s): HIV Infections Last Updated: January 31, 2013Recruiting
89
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
Condition(s): Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee Last Updated: April 30, 2013Recruiting
90
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Condition(s): Diabetes Mellitus, Type 2 Last Updated: June 27, 2011Completed
91
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer
Condition(s): Oropharynx Cancer; Hypopharynx Cancer Last Updated: October 31, 2012Terminated
92
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
Condition(s): Ulcerative Colitis Last Updated: April 2, 2012Not yet recruiting
93
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
Condition(s): Ulcerative Colitis Last Updated: February 28, 2012Not yet recruiting
94
Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
Condition(s): Asthma Last Updated: January 22, 2008Completed
95
International Immune Tolerance Study
Condition(s): Hemophilia A With Inhibitors Last Updated: December 4, 2009Terminated
96
Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.
Condition(s): Renal Cell Carcinoma Last Updated: June 25, 2012Completed
97
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.
Condition(s): HIV-1 Last Updated: December 20, 2012Approved for marketing
98
Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients
Condition(s): Squamous Cell Carcinoma of Nasopharynx; Squamous Cell Carcinoma of Oropharynx; Squamous Cell Carcinoma of Hypopharynx Last Updated: February 6, 2013Completed
99
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
Condition(s): Head and Neck Cancer Last Updated: October 5, 2011Completed
100
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
Condition(s): Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer Last Updated: May 7, 2013Completed
